TUSC2 and non-small cell lung carcinoma: Loss or reduction of TUSC2 has been reported in non-small cell lung carcinomas (NSCLC), in small cell lung carcinomas [4], in mesothelioma [5], in oesophageal carcinoma [6], in glioblastoma [7] and in sarcomas [8].